Patents by Inventor Hans-Joerg Moebius

Hans-Joerg Moebius has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMBINATION THERAPY USING 1-AMINOCYCLOHEXANE DERIVATIVES AND ACETYLCHOLINESTERASE INHIBITORS
    Publication number: 20210169864
    Abstract: The invention relates to a novel drug combination therapy useful in the treatment of dementia comprising administering a 1-aminocyclohexane derivative such as memantine and an acetylcholinesterase inhibitor (AChEI) such as donepezil.
    Type: Application
    Filed: February 18, 2021
    Publication date: June 10, 2021
    Inventor: Hans-Joerg MOEBIUS
  • COMBINATION THERAPY USING 1-AMINOCYCLOHEXANE DERIVATIVES AND ACETYLCHOLINESTERASE INHIBITORS
    Publication number: 20160136144
    Abstract: The invention relates to a novel drug combination therapy useful in the treatment of dementia comprising administering a 1-aminocyclohexane derivative such as memantine and an acetylcholinesterase inhibitor (AChEI) such as donepezil.
    Type: Application
    Filed: January 28, 2016
    Publication date: May 19, 2016
    Inventor: Hans-Joerg MOEBIUS
  • COMBINATION THERAPY USING 1-AMINOCYCLOHEXANE DERIVATIVES AND ACETYLCHOLINESTERASE INHIBITORS
    Publication number: 20140371260
    Abstract: The invention relates to a novel drug combination therapy useful in the treatment of dementia comprising administering an 1-aminocyclohexane derivative such as memantine or neramexane and an acetylcholinesterase inhibitor (AChEI) such as galantamine, tacrine, donepezil, or rivastigmine.
    Type: Application
    Filed: May 16, 2014
    Publication date: December 18, 2014
    Applicant: MERZ PHARMA GmbH & CO. KGaA
    Inventor: Hans-Joerg Moebius
  • Combination therapy using 1-aminocyclohexane derivatives and acetylcholinesterase inhibitors
    Publication number: 20100227852
    Abstract: The invention relates to a novel drug combination therapy useful in the treatment of dementia comprising administering an 1-aminocyclohexane derivative such as memantine or neramexane and an acetylcholinesterase inhibitor (AChEI) such as galantamine, tacrine, donepezil, or rivastigmine.
    Type: Application
    Filed: March 22, 2010
    Publication date: September 9, 2010
    Applicant: MERZ PHARMA GmbH & CO. KGaA
    Inventor: Hans-Joerg Moebius
  • Memantine For The Treatment Of Childhood Behavioral Disorders
    Publication number: 20100081723
    Abstract: The present invention provides a method for the treatment of individuals diagnosed with a childhood behavioral disorder such as autistic spectrum disorders or combined type Attention-Deficit/Hyperactivity Disorder (ADHD) by administering an effective amount of memantine.
    Type: Application
    Filed: October 30, 2009
    Publication date: April 1, 2010
    Applicant: FOREST LABORATORIES HOLDINGS LIMITED
    Inventors: Jeffrey Jonas, Pradeep K. Banerjee, Sandeep Gupta, Allison Mann, Hans-Joerg Moebius
  • Memantine For The Treatment Of Mild And Mild To Moderate Alzheimer's Disease
    Publication number: 20100048726
    Abstract: The present invention provides a method for the treatment, prevention, or delay of progression of mild, or mild-to-moderate Alzheimer's disease, by administering an effective dose of memantine. The present invention also provides a method for preventing the decrease in glucose metabolism in the cortical and sub-cortical regions of the brain in subjects with mild, or mild-to-moderate Alzheimer's disease.
    Type: Application
    Filed: October 29, 2009
    Publication date: February 25, 2010
    Applicant: FOREST LABORATORIES HOLDINGS LIMITED
    Inventors: Scott McDonald, Ivan Gergel, Steven Potkin, Albrecht Stöffler, Yvonne Wirth, Hans-Joerg Moebius
  • Combination therapy using 1-aminocyclohexane derivatives and acetylcholinesterase and inhibitors
    Publication number: 20090124659
    Abstract: The invention relates to a novel drug combination therapy useful in the treatment of dementia comprising administering an 1-aminocyclohexane derivative such as memantine or neramexane and an acetylcholinesterase inhibitor (AChEI) such as galantamine, tacrine, donepezil, or rivastigmine.
    Type: Application
    Filed: February 27, 2008
    Publication date: May 14, 2009
    Applicant: MERZ PHARMA GMBH & CO. KGAA
    Inventor: Hans-Joerg Moebius
  • Memantine for the treatment of childhood behavioral disorders
    Publication number: 20060079582
    Abstract: The present invention provides a method for the treatment of individuals diagnosed with a childhood behavioral disorder such as autistic spectrum disorders or combined type Attention-Deficit/Hyperactivity Disorder (ADHD) by administering an effective amount of memantine.
    Type: Application
    Filed: September 23, 2005
    Publication date: April 13, 2006
    Inventors: Jeffrey Jonas, Pradeep Banerjee, Sandeep Gupta, Allison Mann, Hans-Joerg Moebius
  • Memantine for the treatment of mild and mild to moderate Alzheimer's disease
    Publication number: 20060020042
    Abstract: The present invention provides a method for the treatment, prevention, or delay of progression of mild, or mild-to-moderate Alzheimer's disease, by administering an effective dose of memantine. The present invention also provides a method for preventing the decrease in glucose metabolism in the cortical and sub-cortical regions of the brain in subjectes with mild, or mild-to-moderate Alzheimer's disease.
    Type: Application
    Filed: January 5, 2005
    Publication date: January 26, 2006
    Applicant: Forest Laboratories, Inc.
    Inventors: Scott McDonald, Ivan Gergel, Steven Potkin, Albrecht Stoffler, Yvonne Wirth, Hans-Joerg Moebius
  • 1-Aminocyclohexane derivatives for the treatment of agitation and other behavioral disorders, especially those associated with alzheimer's disease
    Publication number: 20050203191
    Abstract: The present invention relates to the treatment of behavioral disorders, especially agitation, associated with a central nervous system (CNS) disorder, especially Alzheimer's disease (AD), cerebrovascular disease (VaD), or Down's Syndrome, in a mammal, comprising administering to said mammal an 1-aminocyclohexane, alone or in combination with a acetylcholinesterase inhibitor. In one embodiment, the 1-aminocyclohexane is memantine.
    Type: Application
    Filed: March 3, 2005
    Publication date: September 15, 2005
    Applicant: Forest Laboratories, Inc.
    Inventors: Scott McDonald, Barry Reisberg, Steven Ferris, Hans-Joerg Moebius, Albrecht Stoffler
  • Combination therapy using 1-aminocyclohexane derivatives and acetylcholinesterase inhibitors
    Publication number: 20040087658
    Abstract: The invention relates to a novel drug combination therapy useful in the treatment of dementia comprising administering an 1-aminocyclohexane derivative such as memantine or neramexane and an acetylcholinesterase inhibitor (AChEI) such as galantamine, tacrine, donepezil, or rivastigmine.
    Type: Application
    Filed: October 23, 2003
    Publication date: May 6, 2004
    Inventor: Hans-Joerg Moebius